Showing results (1-10 of 131) with videos related to
Sort By:
Pageof 14
Molecular Biology Reports|May 2, 2026
The role of protein prenylation in kidney diseases: Molecular basis and therapeutic implicationsRohan Bhadange, Anil Bhanudas GaikwadNaunyn-Schmiedeberg'S Archives of Pharmacology|December 4, 2025
Risedronate attenuates renal fibrosis by targeting prenylation-dependent RhoA/ROCK1 and ERK/NF-κB signalingRohan Bhadange, Anil Bhanudas GaikwadThe Journal of Pharmacy and Pharmacology|January 20, 2025
Repurposing the familiar: Future treatment options against chronic kidney diseaseRohan Bhadange, Anil Bhanudas GaikwadDrug Discovery Today|July 16, 2025
Unlocking new frontiers in kidney diseases: targeting endothelial dysfunction with emerging biomarkers and therapiesRohan Bhadange, Anil Bhanudas GaikwadPathology, Research and Practice|February 17, 2026
Modulation of AKT/GSK-3β signaling by ambrisentan alleviates chronic kidney diseaseRohan Bhadange, Anil Bhanudas GaikwadBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 4, 2025
Levosimendan mitigates renal fibrosis via TGF-β1/Smad axis modulation in UUO ratsRohan Bhadange, Neha Dagar, Anil Bhanudas GaikwadBiochemical and Biophysical Research Communications|April 3, 2025
Combination of α-Klotho and telmisartan attenuates diabetic kidney disease via mitigating EMT, inflammation and apoptosisAnil Bhanudas Gaikwad, Aditya Dipakrao Hajare, Hrushikesh Kulkarni, et al.Cardiovascular Research|September 6, 2018
Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathyVajir Malek, Anil Bhanudas GaikwadBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 19, 2017
Neprilysin inhibitors: A new hope to halt the diabetic cardiovascular and renal complications?Vajir Malek, Anil Bhanudas GaikwadEuropean Journal of Pharmacology|September 26, 2017
AT2 receptor agonist Compound 21: A silver lining for diabetic nephropathyAnuradha Pandey, Anil Bhanudas GaikwadPageof 14